Overview

Safety, Tolerability, and Preliminary Efficacy of HRS-7450 Injection in the Treatment of Acute Ischemic Stroke: a Multi-center, Randomized, Double-blind, Double-dummy, Placebo-controlled Clinical Trial

Status:
COMPLETED

Trial end date:
2025-06-11

Target enrollment:

Participant gender:

Summary

This study is a multi-center, randomized, double-blind, double-dummy, placebo-controlled, single dose escalation study aimed at evaluating the overall safety, tolerability, and preliminary efficacy of HRS-7450 in patients with acute ischemic stroke.

Phase:

PHASE1

Details

Lead Sponsor:

Fujian Shengdi Pharmaceutical Co., Ltd.

Treatments:

Sodium Chloride